Loading...
Chemical structure of CDKI-73

GC19096

CDKI-73

Also known as 3-[[5-fluoro-4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide

CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM; shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM)

ChemicalCAS1421693-22-2MW394.45FormulaC15H15FN6O2S2
CAS number
1421693-22-2
Molecular weight
394.45
Formula
C15H15FN6O2S2
Solubility
DMSO ： ≥ 52 mg/mL (131·83 mM);Water ： ＜ 0·1 mg/mL (insoluble)
InChIKey
GAIOPWBQKZMUNO-UHFFFAOYSA-N
Catalogue number
GC19096
Brand
GLPBIO
Computed properties PubChem CID 71561915 · XLogP 2.2 · TPSA 160 Ų · H-bond donors 3
XLogP
2.2
TPSA
160 Ų
H-bond donors
3
H-bond acceptors
10
Rotatable bonds
5
Heavy atoms
26

SMILES CC1=C(SC(=N1)NC)C2=NC(=NC=C2F)NC3=CC(=CC=C3)S(=O)(=O)N

Computed descriptors from PubChem (CID 71561915), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.